Cellular Therapy Strategies Offer the Prospect of Deep Remissions for Multiple Myeloma
The FDA approval of the first chimeric antigen receptor T-cell therapy in March 2021 for the treatment of relapsed/refractory multiple myeloma represents a significant advance.
Dr. Hillengass on Imaging Modalities in Multiple Myeloma
Jens Hillengass, MD, discusses available imaging modalities in multiple myeloma.
New Myeloma Guidelines Reflect Advances in Imaging, Explosion of Treatment Options
Imaging approaches and technologies have advanced dramatically since the last such guidance was developed a decade ago, driving earlier and more effective detection and treatment.
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations
2 Clarke Drive Cranbury, NJ 08512